MedPath

Greenwich LifeSciences

Greenwich LifeSciences logo
🇺🇸United States
Ownership
Public
Established
2006-01-01
Employees
7
Market Cap
$183.8M
Website
http://www.greenwichlifesciences.com
Introduction

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Phase 3
Recruiting
Conditions
Breast Cancer
Interventions
Biological: Placebo
First Posted Date
2022-02-10
Last Posted Date
2025-06-24
Lead Sponsor
Greenwich LifeSciences, Inc.
Target Recruit Count
598
Registration Number
NCT05232916
Locations
🇺🇸

Arizona Oncology Associates - Tucson, Tucson, Arizona, United States

🇺🇸

Arizona Oncology Associates - Tucson, Tucson, Arizona, United States

🇺🇸

Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center, Fullerton, California, United States

and more 302 locations
© Copyright 2025. All Rights Reserved by MedPath